For the nine months ended September 30, 2022, we had a net income of $1,690,242, which consists of changes in fair value of the warrant liabilities of $2,976,000, interest earned on marketable securities held in Trust Account of $670,720, and provision for income taxes of $(69,477), offset by operating and formation costs of $1,887,001.
For the three months ended September 30, 2021, we had a net income of $1,041,503, which consists of interest earned on marketable securities held in the Trust Account of $2,928, changes in fair value of the warrant liabilities of $1,256,100, offset by operating and formation costs of $217,525.
For the nine months ended September 30, 2021, we had a net income of $3,089,413, which consists of changes in fair value of the warrant liabilities of $3,801,300 and interest earned on marketable securities held in the Trust Account of $7,352, offset by operating and formation costs of $632,695 and transaction costs associated with the IPO of $86,544.
Liquidity and Capital Resources
On February 11, 2021, the Company consummated the IPO of 11,500,000 Adara Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 1,500,000 Adara Units, at $10.00 per Adara Unit, generating gross proceeds of $115,000,000. Simultaneously with the closing of the IPO, the Company consummated the sale of 4,120,000 Private Warrants, at a price of $1.00 per Private Warrant in a private placement to the Sponsor, generating gross proceeds of $4,120,000.
For the year ended December 31, 2021, cash used in operating activities was $340,634. Net income of $3,244,206 was impacted by interest earned on marketable securities held in the Trust Accounts of $10,281, change in fair value of warrant liabilities of $4,297,300 and transaction cost incurred in connection with IPO of $86,544. Changes in operating assets and liabilities, which provided $636,197 of cash from operating activities.
For the period from August 5, 2020 (inception) through December 31, 2020, cash used in operating activities was $400,594. Net loss of $5,476 was impacted by changes in operating assets and liabilities, which used $395,118 of cash from operating activities.
For the nine months ended September 30, 2022, cash used in operating activities was $1,130,985. Net income of $1,690,242 was affected by the change in fair value of the warrant liabilities of $2,976,000 and interest earned on marketable securities of $670,720. Changes in operating assets and liabilities provided $825,493 of cash for operating activities.
For the nine months ended September 30, 2021, cash used in operating activities was $220,098. Net income of $3,089,413 was affected by the change in fair value of the warrant liabilities of $3,801,300, transaction costs associated with the IPO of $86,544 and interest income on marketable securities of $7,352. Changes in operating assets and liabilities provided $412,597 of cash for operating activities.
As of September 30, 2022, we had marketable securities held in the Trust Account of $116,831,001 (including $681,001 of interest income) consisting of U.S. Treasury Bills with a maturity of 185 days or less. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through September 30, 2022, we have not withdrawn any interest earned from the Trust Account.
We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our initial business combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2022, we had cash of $29,502 held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.